Intensive hemodialysis associates with improved survival compared with conventional hemodialysis

Journal of the American Society of Nephrology

Volumn 23, Issue 4, 2012, Pages 696-705

  Nesrallah, Gihad E ^a,b   Lindsay, Robert M ^a   Cuerden, Meaghan S ^a   Garg, Amit X ^a,b   Port, Friedrich ^c   Austin, Peter C ^d,e   Moist, Louise M ^a   Pierratos, Andreas ^f   Chan, Christopher T ^f   Zimmerman, Deborah ^g   Lockridge, Robert S ^h   Couchoud, Cécile ⁱ   Chazot, Charles ^j   Ofsthun, Norma ^k   Levin, Adeera ^l   Copland, Michael ^l   Courtney, Mark ^m   Steele, Andrew ⁿ   McFarlane, Philip A ^f   Geary, Denis F ^f   Pauly, Robert P ^m   Komenda, Paul ^o   Suri, Rita S ^a   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ Agence de la Biomedecine   (France)

^j NephoCare Tassin Charcot   (France)

^k FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ LAKERIDGE HEALTH CORPORATION   (Canada)

^o UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CONVENTIONAL CENTER HEMODIALYSIS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INTENSIVE HOME HEMODIALYSIS; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION;

EID: 84859851344     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011070676     Document Type: Article

References (32)

1. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reducedmortality in theDOPPS. Kidney Int 69: 1222-1228, 2006
2. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9[Suppl]: S16-S23, 1998
3. Weinreich T, De los Ríos T, Gauly A, Passlick-Deetjen J: Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol 66: 433-439, 2006 (Pubitemid 44896152)
4. Powell JR, Oluwaseun O, Woo YM, Padmanabhan N, Narasinghan E, Latta C, Tortolano J, Jardine AG, Geddes CC: Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 4: 1097-1101, 2009
5. Lacson E Jr, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 5: 220-226, 2010
6. PaulyRP, Gill JS,RoseCL, AsadRA,CheryA, PierratosA,ChanCT: Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 24: 2915-2919, 2009
7. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb- Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: A USRDS study. Kidney Int 76: 984-990, 2009
8. Shariff SZ, Cuerden MS, Jain AK, Garg AX: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19: 841-843, 2008
9. Blagg CR: First use of nocturnal hemodialysis. Kidney Int 76: 917, 2009
10. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM: Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42[Suppl]: 13-17, 2003
11. Chan CT, Li SH, Verma S: Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in endstage renal disease. Am J Physiol Renal Physiol 289: F679-F684, 2005 (Pubitemid 41324188)
12. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007 (Pubitemid 47443343)
13. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK,Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003 (Pubitemid 37509303)
14. Woods JD, Port FK, Stannard D, Blagg CR, Held PJ: Comparison of mortality with home hemodialysis and center hemodialysis: A national study. Kidney Int 49: 1464-1470, 1996 (Pubitemid 26166422)
15. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. JAmSocNephrol 21: 499-506, 2010
16. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath- Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S: The effects of frequent nocturnal home hemodialysis: The FrequentHemodialysisNetworkNocturnal Trial. Kidney Int 80: 1080-1091, 2011
17. Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS Jr Frequent Hemodialysis Network Trial Group: Recruitment and training for home hemodialysis: Experience and lessons from the Nocturnal Dialysis Trial. Clin J Am Soc Nephrol 5: 1614-1620, 2010
18. Komenda P, Garfield S, White Poret A, Sood M, Gavaghan M: A costing model for use in evaluating the fiscal impact of home versus in-center dialysis within various healthcare systems [abstract TH-FC124]. Presented at the American Society of Nephrology Renal Week 2010, Denver, CO, November 18, 2010
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370: 1453-1457, 2007
20. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis 44[Suppl 2]: 7-15, 2004
21. Nesrallah GE, Moist LM, Awaraji C, Lindsay RM: An international registry to compare quotidian dialysis regimens with conventional thriceweekly hemodialysis: Why, how, and potential pitfalls. Semin Dial 17: 131-135, 2004 (Pubitemid 38560985)
22. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C: The Renal Epidemiology and Information Network (REIN): A new registry for end-stage renal disease in France. Nephrol Dial Transplant 21: 411-418, 2006 (Pubitemid 43159996)
23. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA: Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42: 125-132, 2003 (Pubitemid 36807661)
24. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55, 1983
25. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 26: 734-753, 2007 (Pubitemid 46206593)
26. Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28: 3083-3107, 2009
27. Bland JM, Altman DG: The logrank test. BMJ 328: 1073, 2004
28. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM: Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330: 960-962, 2005
29. UCLA Academic Technology Services, Statistical Consulting Group: Introduction to SAS. Available at: http://www.ats.ucla.edu/stat/sas. Accessed January 27, 2012
30. Austin PC: Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. AmJ Epidemiol 172: 1092-1097, 2010
31. Selvin S: Variation in bias. In: Statistical Analysis of Epidemiologic Data. 3rd Ed., Cary, NC, Oxford University Press, 2004, pp 54-69
32. Altman DG, Bland JM: Interaction revisited: The difference between two estimates. BMJ 326: 219, 2003 (Pubitemid 36143396)